Firazyr of Limited Help with Angioedema Caused by ACE Inhibitors, Pooled Trial Data Suggest
Firazyr (icatibant acetate) does not appear to be superior to placebo or symptomatic therapies in treating attacks of angioedema (swelling) caused by angiotensin-converting enzyme (ACE) inhibitors, a pooled analysis of three clinical studies shows. In all trials combined, injections of Firazyr considerably shortened mean time to…